- Home
- IMNN vs COSM Comparison
IMNN vs COSM Comparison
Compare IMNN & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- COSM
- Stock Information
- Founded
- IMNN 1982
- COSM 2009
- Country
- IMNN United States
- COSM United States
- Employees
- IMNN N/A
- COSM N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- IMNN Health Care
- COSM Health Care
- Exchange
- IMNN Nasdaq
- COSM Nasdaq
- Market Cap
- IMNN 12.1M
- COSM 12.3M
- IPO Year
- IMNN 1985
- COSM 2013
- Fundamental
- Price
- IMNN $5.75
- COSM $0.94
- Analyst Decision
- IMNN Buy
- COSM
- Analyst Count
- IMNN 2
- COSM 0
- Target Price
- IMNN $182.61
- COSM N/A
- AVG Volume (30 Days)
- IMNN 55.7K
- COSM 481.2K
- Earning Date
- IMNN 11-06-2025
- COSM 11-13-2025
- Dividend Yield
- IMNN N/A
- COSM N/A
- EPS Growth
- IMNN N/A
- COSM N/A
- EPS
- IMNN N/A
- COSM N/A
- Revenue
- IMNN N/A
- COSM $55,093,442.00
- Revenue This Year
- IMNN N/A
- COSM $28.14
- Revenue Next Year
- IMNN N/A
- COSM N/A
- P/E Ratio
- IMNN N/A
- COSM N/A
- Revenue Growth
- IMNN N/A
- COSM N/A
- 52 Week Low
- IMNN $4.83
- COSM $0.28
- 52 Week High
- IMNN $41.22
- COSM $1.28
- Technical
- Relative Strength Index (RSI)
- IMNN 36.86
- COSM 62.17
- Support Level
- IMNN $5.53
- COSM $0.56
- Resistance Level
- IMNN $5.89
- COSM $0.85
- Average True Range (ATR)
- IMNN 0.32
- COSM 0.09
- MACD
- IMNN 0.07
- COSM 0.00
- Stochastic Oscillator
- IMNN 23.81
- COSM 74.52
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.